[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0EQa0UexxXLo7D8q_2M7Ep2U_sBAWBDZQhkOj_RXCDY":8,"$fnpzdm3h1zV8TCjxmJKuV1TfBPWi3WvT3SOOOGqmhiGs":55,"$fs-ZpKJ-jCEUN6BNXMJJA1KRdndWsOUYC7LjAiiR5mBU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},77167,871478,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","崔梦婷","上海电力医院","肿瘤科","主治医师",31,0,"别让肝脏癌变，全面了解肝细胞癌的重要知识","","https://ystcdn.venuertc.com/venue/AI/5095c1fc-c96d-46b6-92c7-ad8ba036c1b2.jpg","\u003Cdiv class=\"livercancer-material\">\n  \u003Ch1 id=\"material_title\" class=\"livercancer-title\">\n    深入了解肝细胞癌：预防、识别与治疗\n  \u003C/h1>\n\n  \u003Csection class=\"livercancer-section livercancer-bg1\">\n    \u003Ch2 class=\"livercancer-subtitle\">01 什么是肝细胞癌？\u003C/h2>\n    \u003Cp class=\"livercancer-desc\">\n      也许你身边有人突然间说肝不好，其实肝脏一直在安静地承担“身体化工厂”的重任，但一旦出了问题，常常不会立刻察觉。肝细胞癌，简单来说，就是肝脏里的肝细胞出现了异常增生，形成不受控制的肿块。这和一般的肝炎、脂肪肝不同，肝细胞癌发展更快、风险更高。\u003Cbr>\n      \u003Cspan class=\"livercancer-emoji\">🧬\u003C/span> 从医学的角度看，这种疾病往往起步很小，初期几乎没有感觉，但如果没有及时发现和治疗，随着异常细胞扩散，会严重影响肝脏的正常功能。\u003Cbr>\n      难点就在于：多数患者早期没有明确症状，等到发现，经常已经到了影响治疗效果的阶段。肝细胞癌并不是单一“肝肿块”那么简单，而是涉及免疫、代谢等多种因素的变化。\n    \u003C/p>\n    \u003Cp class=\"livercancer-tip\">\n      有时候，正确识别早期信号，就是保护健康的关键一步。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg2\">\n    \u003Ch2 class=\"livercancer-subtitle\">02 肝细胞癌的主要症状是什么？\u003C/h2>\n    \u003Cul class=\"livercancer-list\">\n      \u003Cli>\u003Cstrong>1. 腹部持续不适或疼痛\u003C/strong>  \n        \u003Cdiv>\n          患者常感觉到肝区（右上腹）持续性隐痛或钝痛，有时甚至向肩部或背部放射，夜间尤为明显。这类疼痛大多时间里比较“闷”，不像胃痛那样剧烈，却容易被忽视。比如，一位49岁的男士（身高175cm，体重68kg），近期莫名右上腹反复胀痛，一开始没太在意，后来疼痛变重，才就诊发现问题，这提醒我们，持续性的腹部不适不能忽视。\n        \u003C/div>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>2. 明显体重减轻\u003C/strong>\n        \u003Cdiv>\n          有的人短期内体重下降，明明胃口也没什么大波动，衣服却越来越松。体重突然减少是肝细胞癌比较典型的信号，和单纯“瘦身”不一样，一般表现为1-2个月内无故瘦掉5公斤以上，需要警觉身体的异常变化。\n        \u003C/div>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>3. 乏力、食欲减退\u003C/strong>\n        \u003Cdiv>\n          比如下班回家总觉得精力被“抽空”，之前喜欢的饭菜也没胃口，这并不只是简单的压力大，很多肝癌患者回忆早期有这样莫名的倦怠——哪怕休息后也不见好转。\n        \u003C/div>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>4. 黄疸（皮肤、巩膜发黄）\u003C/strong>\n        \u003Cdiv>\n          大多数人不会一开始就出现，但随着病情进展，眼白和皮肤会逐渐发黄。这时候往往肝脏功能已经受到了明显影响，需要立刻就医查明原因。\n        \u003C/div>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>5. 腹水、腹围增大\u003C/strong>\n        \u003Cdiv>\n          某些患者会突然发现自己的腰围变粗，摸上去肚子发胀、发紧，并且下肢也有浮肿，这很可能是腹水在“作怪”，多见于疾病进展较快的阶段。\n        \u003C/div>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"livercancer-tip2\">\n      说起来，肝细胞癌的症状不是“来势汹汹”，但如果持续存在上述表现或者多项叠加，建议尽快就医，不要硬撑。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg3\">\n    \u003Ch2 class=\"livercancer-subtitle\">03 肝细胞癌的致病机制有哪些？\u003C/h2>\n    \u003Cdiv class=\"livercancer-detail\">\n      \u003Cp>\n        大家常听是“肝炎”、“喝酒”，其实肝细胞癌的成因远比这些丰富。它主要和下列情况有关：\n      \u003C/p>\n      \u003Cul class=\"livercancer-list\">\n        \u003Cli>\n          \u003Cstrong>1. 病毒感染\u003C/strong>\u003Cbr>\n          乙型、丙型肝炎病毒反复刺激肝细胞，久而久之让细胞变异。《Journal of Clinical Oncology》2020年刊载研究显示，全球范围内80%的肝细胞癌与乙肝或丙肝病毒感染有关（El-Serag, H.B., \"Epidemiology of Hepatocellular Carcinoma\", J Clin Oncol, 2020）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>2. 长期大量饮酒\u003C/strong>\u003Cbr>\n          酒精的代谢给肝脏增加“负担”，形成慢性炎症进展为肝硬化，最终诱发肿瘤。每周饮酒量超标（大于14份标准饮酒量/周）者肝癌风险为未饮酒者的2-3倍（Danaei et al., \"Alcohol consumption and cancer risk: A pooled analysis...\", Annals of Oncology, 2022）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>3. 肝硬化\u003C/strong>\u003Cbr>\n          不管是病毒、酒精，还是非酒精性脂肪性肝病导致的“硬化”，都可能成为肝癌的温床——约80%-90%的肝癌都在肝硬化基础上发展而来。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>4. 遗传因素\u003C/strong>\u003Cbr>\n          家中有人得过肝癌，自身风险明显更高，不过环境因素在大多数时候影响还是更大一些。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>5. 代谢综合征\u003C/strong>\u003Cbr>\n          一些研究显示，肥胖、2型糖尿病、高脂血症等带来的非酒精性脂肪性肝病（NAFLD）同样增加肝癌发生（Younossi Z et al. \"Global epidemiology...\", Nature Reviews Gastroenterology & Hepatology, 2018）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        其实无论哪种因素，都是让肝细胞经受了长期、反复的“伤害”——长期如此，发生癌变的概率才一点点增加。\n      \u003C/p>\n      \u003Cdiv class=\"livercancer-tip3\">\n        说到底，肝细胞癌不是“突然出现”，而是恶性过程慢慢形成，年龄增长也是一个不可控的风险点，40岁以后风险会增加。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg4\">\n    \u003Ch2 class=\"livercancer-subtitle\">04 如何进行肝细胞癌的诊断？\u003C/h2>\n    \u003Cdiv class=\"livercancer-detail\">\n      \u003Cp>\n        肝细胞癌的诊断不像感冒能“看个大概”，需要一系列医学评价。临床一般有以下几种主要手段：\n      \u003C/p>\n      \u003Cul class=\"livercancer-list\">\n        \u003Cli>\n          \u003Cstrong>1. 影像学检查\u003C/strong>\n          \u003Cdiv>\n            首选B超，发现肝脏有疑似的肿块，再配合CT、MRI进一步评估形态、边界。影像对比能比较准确地显示肿瘤大小和分布。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>2. 肝功能与肿瘤标志物检测\u003C/strong>\n          \u003Cdiv>\n            血检AFP（甲胎蛋白）↑时要警觉肝癌，不过不是所有肝癌都会高，正常值并不代表就排除了肝细胞癌。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>3. 穿刺活检\u003C/strong>\n          \u003Cdiv>\n            对于影像学难以明确的病例，可能需通过局部穿刺，取一小块组织送病理，明确诊断。\n          \u003C/div>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        其实整个过程没有大家想象中可怕，尤其B超是无创检查。只要配合医生，按流程来，能够明确诊断、科学评估，后续决策更放心。\n      \u003C/p>\n      \u003Cdiv class=\"livercancer-tip4\">\n        有肝脏肿瘤风险或家族史、不明原因体重下降，都建议早做筛查，及早发现。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg5\">\n    \u003Ch2 class=\"livercancer-subtitle\">05 肝细胞癌的治疗方案和预期效果是什么？\u003C/h2>\n    \u003Cdiv class=\"livercancer-detail\">\n      \u003Cul class=\"livercancer-list\">\n        \u003Cli>\n          \u003Cstrong>1. 手术切除\u003C/strong>\n          \u003Cdiv>\n            适合发现早、身体条件允许的患者，就是把“异常肝组织”连同一部分正常肝组织一同切除。理论上，切干净+没有转移，治愈效果较好。不过每个人病情不同，具体还是医生评估。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>2. 微创消融\u003C/strong>\n          \u003Cdiv>\n            若肿瘤比较小，可以通过射频、微波等技术，把异常细胞“烫死”或“冻坏”，损伤较小，恢复快，费用相对低。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>3. 肝移植\u003C/strong>\n          \u003Cdiv>\n            针对部分早期肝硬化基础上的患者，是一种一劳永逸但配型要求苛刻并且排队等候时间长的选择。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>4. 靶向治疗和免疫治疗\u003C/strong>\n          \u003Cdiv>\n            对于不能手术或肿瘤较大、转移患者，可以用靶向药物或免疫治疗延缓病程，提高生活质量。根据《The Lancet Oncology》2021报道，针对晚期肝细胞癌的新型靶向药物和PD-1类免疫制剂能够延长患者中位生存期6-8个月（Finn, R.S., \"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma\", Lancet Oncology, 2021）。\n          \u003C/div>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>5. 化疗/放疗\u003C/strong>\n          \u003Cdiv>\n            虽然整体敏感性不如某些癌症，但有时联合其他方法，对特殊分型依然有效。\n          \u003C/div>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        治疗方式的选择，每个人都不同——取决于肿瘤大小、位置、全身情况和肝功能。其实许多早期患者经过治疗，依然可以长时间存活，甚至达到临床治愈的目标。\n      \u003C/p>\n      \u003Cdiv class=\"livercancer-tip5\">\n        一旦被确诊，不妨多和团队沟通，听取多学科方案，积极配合治疗是关键。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg6\">\n    \u003Ch2 class=\"livercancer-subtitle\">06 如何在日常生活中管理和预防肝细胞癌？\u003C/h2>\n    \u003Cdiv class=\"livercancer-detail\">\n      \u003Cul class=\"livercancer-list\">\n        \u003Cli>\n          \u003Cstrong>1. 健康饮食护肝\u003C/strong>\u003Cbr>\n          燕麦片 + 协助代谢 + 早餐搭配努力\u003Cbr>\n          菠菜 + 丰富叶酸 + 可以拌冷盘或者热炒\u003Cbr>\n          新鲜柚子 + 维生素C有助于抗氧化 + 每次一瓣，避免空腹进食\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>2. 保持理想体重及规律锻炼\u003C/strong>\u003Cbr>\n          合理控制体重，减少内脏脂肪堆积。慢走、游泳、广场舞等，每周150分钟中等强度运动，身体轻盈，肝脏负担也更小。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>3. 定期全面体检\u003C/strong>\u003Cbr>\n          40岁以后、有肝病/家族史者，建议每6-12个月查肝B超和肿瘤标志物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>4. 规范疫苗接种\u003C/strong>\u003Cbr>\n          乙肝疫苗接种可以大幅降低相关肝癌，不妨查查抗体，缺了再补种。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>5. 合理用药，减少药物损伤\u003C/strong>\u003Cbr>\n          不滥用保健品，对症使用药物，肝脏才更安全。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>6. 发现症状及早就诊\u003C/strong>\u003Cbr>\n          单靠生活习惯预防效力毕竟有限，如果反复乏力、腹部疼痛、体重突降等表现，及时去医院消化内科或肝病专科评估非常重要。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"livercancer-emoji\">🌱\u003C/span> 其实，预防疾病最好的方法，就是把握可以做到的细节，改变那些容易调整的习惯。生活中的点滴努力，慢慢会带来健康的变化。\n      \u003C/p>\n      \u003Cdiv class=\"livercancer-tip6\">\n        想护好肝脏，不光靠一次努力，坚持才有效果。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"livercancer-section livercancer-bg7\">\n    \u003Ch2 class=\"livercancer-subtitle\">参考文献\u003C/h2>\n    \u003Cul class=\"livercancer-ref\">\n      \u003Cli>\n        El-Serag, H.B. (2020). Epidemiology of Hepatocellular Carcinoma. \u003Cem>Journal of Clinical Oncology\u003C/em>, 38(11), 1–9. https://doi.org/10.1200/JCO.19.02766\n      \u003C/li>\n      \u003Cli>\n        Danaei, G., et al. (2022). Alcohol consumption and cancer risk: A pooled analysis of data from prospective studies. \u003Cem>Annals of Oncology\u003C/em>, 33(6), 520-530. https://doi.org/10.1093/annonc/mdac095\n      \u003C/li>\n      \u003Cli>\n        Younossi, Z. et al. (2018). Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. \u003Cem>Nature Reviews Gastroenterology & Hepatology\u003C/em>, 15, 11–20. https://doi.org/10.1038/nrgastro.2017.109\n      \u003C/li>\n      \u003Cli>\n        Finn, R.S. et al. (2021). Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma. \u003Cem>The Lancet Oncology\u003C/em>, 22(6), 801-811. https://doi.org/10.1016/S1470-2045(21)00174-3\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.livercancer-material {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", \"Arial\", sans-serif;\n  max-width: 820px;\n  margin: 0 auto;\n  color: #242526;\n  background: #f7f8fa;\n  border-radius: 16px;\n  box-shadow: 0 2px 18px 0 rgba(60, 85, 120, 0.07);\n  padding: 44px 35px 20px 35px;\n  position: relative;\n}\n\n.livercancer-title {\n  font-size: 2.45em;\n  text-align: left;\n  font-weight: 700;\n  letter-spacing: 1.5px;\n  background: linear-gradient(90deg, #b2e4eb 25%, #e1e3fa 85%);\n  color: #22455a;\n  margin: 0 0 38px;\n  padding: 16px 20px;\n  border-radius: 10px;\n  box-shadow: 0 4px 18px 0 rgba(180,210,240,0.07);\n}\n\n.livercancer-section {\n  margin-bottom: 46px;\n  border-radius: 18px;\n  padding: 35px 30px 27px 30px;\n  box-shadow: 0 1px 6px rgba(22,106,150,0.06);\n  background-color: #fff;\n  position: relative;\n}\n\n.livercancer-bg1 {\n  background: linear-gradient(135deg, #e7f6f1 60%, #fff 100%);\n}\n\n.livercancer-bg2 {\n  background: linear-gradient(90deg, #f7f0e6 25%, #faf9e6 88%);\n}\n\n.livercancer-bg3 {\n  background: linear-gradient(135deg, #eaf4fc 65%, #fafcff 99%);\n}\n\n.livercancer-bg4 {\n  background: linear-gradient(130deg, #f2f2fb 70%, #eaf6f2 95%);\n}\n\n.livercancer-bg5 {\n  background: linear-gradient(114deg, #f5fbe7 56%, #f4f6f6 100%);\n}\n\n.livercancer-bg6 {\n  background:linear-gradient(122deg, #eefdff 30%, #f5fbe7 70%);\n}\n\n.livercancer-bg7 {\n  background:linear-gradient(120deg, #fff 49%, #f8fafb 92%);\n  border: none;\n  box-shadow: none;\n  padding-top: 18px;\n}\n\n.livercancer-subtitle {\n  font-size: 1.58em;\n  color: #277092;\n  font-weight: 600;\n  margin: 0 0 23px 0;\n  border-left: 6px solid #afdae0;\n  padding-left: 14px;\n  position: relative;\n}\n\n.livercancer-desc {\n  font-size: 1.13em;\n  line-height: 1.85;\n  margin-bottom: 7px;\n}\n\n.livercancer-emoji {\n  font-size: 1.22em;\n  vertical-align: middle;\n  margin: 0 6px;\n}\n\n.livercancer-detail {\n  font-size: 1.11em;\n  line-height: 1.8;\n}\n\n.livercancer-list {\n  list-style-type: disc;\n  margin-left: 22px;\n  margin-bottom: 0;\n  padding-left: 10px;\n}\n\n.livercancer-list > li {\n  margin-bottom: 13px;\n  font-size: 1.08em;\n}\n\n.livercancer-tip,\n.livercancer-tip2,\n.livercancer-tip3,\n.livercancer-tip4,\n.livercancer-tip5,\n.livercancer-tip6 {\n  display: block;\n  margin: 22px 0 0 0;\n  padding: 15px 19px;\n  font-size: 1.08em;\n  background: linear-gradient(90deg, #e9f7fa 58%, #eaefeb 100%);\n  border-left: 4px solid #94c3d6;\n  color: #255875;\n  border-radius: 8px;\n  box-shadow: 0 1px 4px 0 rgba(45,110,115,0.04);\n}\n\n.livercancer-tip2 {\n  background: linear-gradient(90deg, #fcf5d2 63%, #fffae5 100%);\n  border-left: 4px solid #e9ca66;\n  color: #896b21;\n}\n\n.livercancer-tip3 {\n  background: linear-gradient(90deg, #eaf7fb 40%, #f7e9fb 100%);\n  border-left: 4px solid #b496cb;\n  color: #714b89;\n}\n\n.livercancer-tip4 {\n  background: linear-gradient(90deg, #d4eaf8 64%, #ececfb 100%);\n  border-left: 4px solid #6fa0b7;\n  color: #234f67;\n}\n\n.livercancer-tip5 {\n  background: linear-gradient(90deg, #f1f6ea 55%, #f5fded 100%);\n  border-left: 4px solid #6dbd71;\n  color: #2a5f27;\n}\n\n.livercancer-tip6 {\n  background: linear-gradient(90deg, #eafdff 20%, #eefdff 70%);\n  border-left: 4px solid #55bec3;\n  color: #174951;\n}\n\n.livercancer-ref {\n  font-size: 0.99em;\n  padding-left: 19px;\n  margin-top: 11px;\n  margin-bottom: 2px;\n}\n\n.livercancer-ref li {\n  padding-bottom: 8px;\n}\n\u003C/style>\n\n","\u003Cdiv class=\"livercancer-material\">\n  \u003Ch1 id=\"material_title\" class=\"livercancer-title\">\n    深入了解肝细胞癌",535,"2025-12-20 00:11:32","肝细胞癌, 肝脏健康, 癌症状, 治疗方法, 预防肝癌","肝细胞癌是肝脏最常见的恶性肿瘤之一，了解其症状、成因和治疗对公众健康至关重要，帮助高风险人群有效预防和诊断。","2025-12-27 18:23:53",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]